82347-6
FDA package insert REMS summary
Active
Part Description
LP221178-9 REMS summary
The risk evaluation and mitigation strategies (REMS) Summary is an overview of what stakeholders who participate in REMS with ETASU, such as healthcare providers, patients, and distributors, are required to do under the REMS' Elements to Assure Safe Use and Implementation System.
Source: U.S. Food and Drug Administration
Fully-Specified Name
- Component
- REMS summary
- Property
- -
- Time
- -
- System
- ^FDA package insert
- Scale
- Nar
- Method
Additional Names
- Short Name
- FDA insert REMS summary
Basic Attributes
- Class
- DOC.REF
- Type
- Clinical
- First Released
- Version 2.58
- Last Updated
- Version 2.58
- Order vs. Observation
- Observation
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Resumen de REMS: |
it-IT | Italian (Italy) | REMS, sintesi: Synonyms: Documentazione di riferimento Foglio illustrativo della Food and Drug Administra Sintesi REMS |
zh-CN | Chinese (China) | REMS 摘要: Synonyms: REMS 摘要(小结); |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=82347-6
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright